FDA inspection
Boehringer Ingelheim Pharma GmbH & Co. KG: FDA inspection ending Jan 23, 2015
FDA inspection 921540 · No Action Indicated (NAI) · Ingelheim am Rhein
Key facts
| Inspection ID | 921540 |
|---|---|
| Firm | Boehringer Ingelheim Pharma GmbH & Co. KG |
| FEI number | 3002806556 |
| Address | Boehringer Ingelheim KG., Binger Str. 173 |
| City | Ingelheim am Rhein |
| Country | Germany |
| Fiscal year | 2015 |
| Inspection end date | Jan 23, 2015 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data